Hanh P. Mai – Projects — Houston Methodist Scholars

View Scopus Profile

h-index

Research activity per year

6 Active
11 Not started

11 results

Filter

Not started

Open Label, Multi-center, Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Autologous CAR BCMA T Cells (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2)
Ganguly, S., Mai, H. P., Petkova, J., Pingali, S. R. & Shah, S.
Project: Clinical Trial
A Phase 3 Open-Label, Randomized Study of Fixed Duration Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab Versus Venetoclax and Rituximab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-322)
Shah, S., Ganguly, S., Mai, H. P., Petkova, J., Pingali, S. R. & Rice, L.
Project: Clinical Trial
BO41843: Phase III_GDC-9545 RO7197597_Breast Cancer_Roche BO41843: A Phase III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of GDC-9545 Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Patients With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
Niravath, P. A., Chang, J. C., Mai, H. P. & Sun, K.
Project: Clinical Trial
Acupuncture Trial
Niravath, P. A., Chang, J. C., Heyne, K., Mai, H. P., Singh, M. & Sun, K.
Project: Clinical Trial
Converting HR Breast Cancer Into an Individualized Vaccine
Chang, J. C., Mai, H. P., Niravath, P. A. & Sun, K.
Project: Clinical Trial
A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in Participants With High-Risk HER2-Positive Primary Breast Cancer Who Have Residual Invasive Disease in Breast
Mai, H. P., Chang, J. C., Niravath, P. A., Sun, K. & Templeton, S.
Project: Clinical Trial
Docetaxel Chemotherapy and Pembrolizumab Plus Interleukin-12 Gene Therapy in Triple Negative Breast Cancer (INTEGRAL)
Chang, J. C., Mai, H. P., Niravath, P. A., Sun, K. & Venta, L. A.
Project: Clinical Trial
Multicenter Phase II Trial of Durvalumab (MEDI4736) With Trastuzumab and Pertuzumab Combination in HER2-Enriched and HER2-Amplified Breast Cancer (DTP Trial)
Chang, J. C., Arentz, C., Mai, H. P., Niravath, P. A. & Sun, K.
Project: Clinical Trial
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC (PRESERVE-001)
Chang, J. C., Mai, H. P., Niravath, P. A. & Sun, K.
Project: Clinical Trial
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
Sun, K., Chang, J. C., Mai, H. P., Niravath, P. A. & Templeton, S.
Project: Clinical Trial
Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene autoleucel (cilta-cel) Out-of-Specification (OOS) in patients with Multiple Myeloma
Ganguly, S., Mai, H. P., Pingali, S. R. & Shah, S.
Project: Clinical Trial